A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...

In cancer care, every day that passes can cost a life. First Ascent Biomedical is racing against that clock. By testing a patient's live cancer cells outside the body, the company reveals how their ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...

SAN JOSE, Calif., March 25, 2025 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...

CINCINNATI (WKRC) — As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized treatment in extending lives beyond a cancer diagnosis.

October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...

As bioprocessing evolves, more than conventional cell lines come into play. In some cases, the bioprocessing of treatments will depend on biobanks of complex tissues. One example involves brain cancer ...

In this discussion with Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, she illustrates how Vanderbilt works to specify each individual patient’s cancer care regimen and treatment path.